Lipid abnormalities among type 2 diabetes mellitus patients: our experience in liorin, Nigeria

被引：0
|
作者：
Katibi, IA
Akande, AA
Salami, AK
机构：
[1] Univ Ilorin, Teaching Hosp, Dept Med, Ilorin, Nigeria
[2] Univ Ilorin, Teaching Hosp, Dept Chem Pathol & Immunol, Ilorin, Nigeria
来源：
TROPICAL DOCTOR | 2004年 / 34卷 / 04期
关键词：
D O I：
10.1177/004947550403400430
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
下载
收藏
页码：254 / 255
页数：2
相关论文
共 50 条
  • [21] ASSESSMENT OF LIPID ABNORMALITIES AND CARDIOVASCULAR RISK INDICES IN TYPE 2DIABETES MELLITUS
    Baral, S.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : A209 - A210
  • [22] Diabetes knowledge among Greek Type 2 Diabetes Mellitus patients
    Poulimeneas, Dimitrios
    Grammatikopoulou, Maria G.
    Bougioukli, Vasiliki
    Iosifidou, Parthena
    Vasiloglou, Maria F.
    Gerama, Maria-Assimina
    Mitsos, Dimitrios
    Chrysanthakopoulou, Ioanna
    Tsigga, Maria
    Kazakos, Kyriakos
    ENDOCRINOLOGIA Y NUTRICION, 2016, 63 (07): : 320 - 326
  • [23] SERUM LIPID ABNORMALITIES IN DIABETES MELLITUS
    SULLIVAN, JF
    LANKFORD, HG
    GRINNELL, EH
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1965, 7 (01): : 28 - &
  • [24] LIPID ABNORMALITIES IN DIABETES-MELLITUS
    VERGES, B
    REVUE DE MEDECINE INTERNE, 1991, 12 (04): : 277 - 281
  • [25] Tesaglitazar improves glucose and lipid abnormalities in patients with type 2 diabetes
    Goldstein, BJ
    Rosenstock, J
    Anzalone, D
    Tou, C
    Öhman, P
    DIABETES, 2005, 54 : A21 - A21
  • [26] Tesaglitazar corrects glucose and lipid abnormalities in patients with type 2 diabetes
    Goldstein, B
    Rosenstock, J
    Tou, C
    Anzalone, D
    Öhman, P
    DIABETOLOGIA, 2005, 48 : A274 - A274
  • [27] Lipid abnormalities and their associations with degree of retinopathy in diabetes mellitus type 1
    Larsson, LI
    Alm, A
    Lithner, F
    Dahlen, G
    Bergstrom, R
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1996, 37 (03) : 4474 - 4474
  • [28] Factors hindering attitude to treatment among patients with type-2 diabetes mellitus in the Niger Delta, Nigeria
    Otovwe, A.
    Oyewole, O.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 103 : S14 - S14
  • [29] Dapagliflozin Effects on the Lipid Profile of Patients With Type 2 Diabetes Mellitus
    Hardy, Elise
    Ptaszynska, Agata
    De Bruin, Tjerk W. A.
    Johnsson, Eva
    Parikh, Shamik J.
    List, James F.
    DIABETES, 2013, 62 : A310 - A310
  • [30] Herbal medicine use among Type 2 diabetes mellitus patients in Nigeria: understanding the magnitude and predictors of use
    Ogochukwu Ukamaka Amaeze
    Roseline Iberi Aderemi-Williams
    Modupeola Anuoluwapo Ayo-Vaughan
    Deborah Aderoju Ogundemuren
    Damilola Segun Ogunmola
    Emmanuel Nwanolue Anyika
    International Journal of Clinical Pharmacy, 2018, 40 : 580 - 588
12345